About Human Formyl Peptide Receptor 1 (FPR1) Stable Cell Line

Formyl Peptide Receptor 1 (FPR1), also known as N-Formyl Peptide Receptor 1, is a Class A G protein-coupled receptor (GPCR) that plays a crucial role in innate immunity and host defense. FPR1 is primarily expressed on neutrophils, monocytes, macrophages, dendritic cells, and other immune cells, where it functions as a pattern-recognition receptor capable of detecting N-formylated peptides derived from bacteria and damaged mitochondria. Upon activation by ligands such as N-formyl-methionyl-leucyl-phenylalanine (fMLF), FPR1 primarily couples to Gi proteins, leading to inhibition of adenylate cyclase activity, intracellular calcium mobilization, activation of MAPK pathways, reactive oxygen species (ROS) production, and directed immune cell migration.

FPR1 serves as a key mediator of chemotaxis, allowing immune cells to rapidly migrate toward sites of infection, inflammation, or tissue injury. The receptor recognizes both pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), enabling rapid initiation of innate immune responses. Beyond its role in antimicrobial defense, FPR1 has been implicated in wound healing, inflammatory diseases, cancer progression, neuroinflammation, and tissue repair processes. Consequently, FPR1 has become an important target for immunology, inflammation, and oncology research.

eEnzyme's Human FPR1 Stable Cell Line provides a reliable and reproducible cellular platform for investigating FPR1-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of formyl peptides, agonists, antagonists, antibodies, and novel receptor modulators through calcium mobilization assays, reporter gene assays, chemotaxis studies, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, ligand profiling, potency determination, lead optimization, and high-throughput screening applications supporting immunology, infectious disease, and inflammation-focused drug discovery programs.

Applications of the FPR1 Stable Cell Line

• FPR1 receptor pharmacology studies
• Innate immune signaling investigations
• Chemotaxis and leukocyte migration research
• Agonist and antagonist screening
• Infectious disease and host-pathogen interaction studies
• Inflammation and immunology research
• Calcium mobilization and GPCR functional assays
• High-throughput screening applications

Biological Significance of FPR1

FPR1 is a critical component of the innate immune system and serves as one of the body's first-line sensors of infection and tissue damage. Activation of FPR1 directs neutrophils and other immune cells toward sites of bacterial invasion through chemotactic signaling, promoting pathogen clearance and inflammatory responses. In addition to its role in antimicrobial defense, FPR1 regulates leukocyte activation, cytokine production, phagocytosis, and oxidative burst responses. Emerging evidence has linked FPR1 signaling to cancer biology, wound repair, ischemia-reperfusion injury, neurodegenerative diseases, and chronic inflammatory disorders. Because FPR1 integrates signals from both microbial and endogenous danger molecules, it represents an important therapeutic target for modulating immune responses in a variety of pathological conditions. The FPR1 Stable Cell Line provides a valuable tool for studying formyl peptide receptor biology and advancing the development of next-generation therapeutics targeting inflammation, infection, and immune-mediated diseases.